前1型糖尿病中的生物标志物发现:Th40细胞作为预测风险因素
该研究基于TrialNet前驱糖尿病受试者血液样本,评估高CD4+CD40+ T细胞(Th40)水平能否作为1型糖尿病(T1D)预测生物标志物。按Th40水平分层后,细胞因子模式和高CD4/CD8双阳性群体分布与对照组和T1D患者的差异模式平行;糖耐量受损者Th40水平显著高于对照组;HLA DR4/DR4和DQ8/DQ8在Th40高水平者中更常见。结论提示依据前驱糖尿病Th40细胞水平的差异,可能设计更准确预测T1D进展及前驱阶段的方法。
要点
- 糖耐量受损者Th40水平显著高于对照组。
- Th40高水平者细胞因子模式不同,CD4/CD8双阳性群体更多。
- HLA DR4/DR4与DQ8/DQ8在Th40高水平者中更常见。
核心结论
- 依据前驱糖尿病Th40细胞水平的差异,可能设计更准确预测个体是否进展为糖尿病及前驱阶段的方法。
研究设计与样本
- 研究评估TrialNet前驱糖尿病受试者血液样本中的Th40水平及其他参数,并按Th40细胞水平进行分层。
主要发现
- 按Th40水平分层的前驱糖尿病受试者中,细胞因子模式与对照组和T1D患者之间的差异模式平行。
- Th40高水平者与低水平者的细胞因子模式显著不同,且Th40高水平组中CD4/CD8双阳性群体更多。
- 糖耐量受损受试者的Th40水平显著高于对照组。
- HLA DR4/DR4和DQ8/DQ8在Th40高水平受试者中更常见;HLA DR4/DR4受试者显著较其他所有受试者年长,提示该单倍型联合高Th40水平可能代表30岁后发生T1D的人群,原文报告42%的T1D病例在30岁后发生。
临床怎么用
- 在前驱糖尿病阶段可考虑检测Th40水平,结合糖耐量状态和HLA DR4/DR4、DQ8/DQ8评估T1D进展风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The incidence of type 1 diabetes (T1D) is increasing worldwide. The quest to understand T1D etiology and how to predict diabetes is ongoing; and, in many ways, those goals intertwine. Although genetic components associate with T1D, not all individuals with T1D have those components, and T1D does not develop in all subjects with those components. OBJECTIVE: More robust methods for prediction of T1D are needed. We investigated if high CD4+CD40+ T-cell (Th40) levels can be used as a biomarker. METHODS: Th40 levels were assessed along with other parameters in blood collected from prediabetic subjects in TrialNet. RESULTS: In prediabetic subjects stratified according to Th40 cell level, patterns paralleled those seen between control subjects and those with T1D. Cytokine patterns were significantly different between those with high Th-40 levels (Th40-high) and those with low levels, and a CD4/CD8 double-positive population was more represented in Th40-high groups. Subjects experiencing impaired glucose tolerance had a significantly higher Th40 level than did control subjects. HLA DR4/DR4 and DQ8/DQ8 were more likely found among Th40-high subjects. Interestingly, HLA DR4/DR4 subjects were significantly older compared with all other subjects, suggesting that this haplotype, together with a high Th40 level, may represent someone in whom T1D will develop after age 30 years, which is reported for 42% of T1D cases. CONCLUSION: Considering the differences found in relation to prediabetic Th40 cell level, it may be possible to devise methods that more accurately predict who will proceed toward diabetes and, possibly, indicate prediabetic stage.
引用
- Vaitaitis GM, Rihanek M, Alkanani AK, et al. Biomarker Discovery in Pre-Type 1 Diabetes; Th40 Cells as a Predictive Risk Factor. J Clin Endocrinol Metab. 2019. PMID: 31063181. doi:10.1210/jc.2019-00364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。